Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bone Allograft Acid Lysates Change the Genetic Signature of Gingival Fibroblasts. | Int J Mol Sci | 2023 | 38003371 | PubTator, text mining | PubMed |
| Role of Akt/Protein Kinase B in Cancer Metastasis. | Biomedicines | 2023 | 38002001 | PubTator, text mining | PubMed |
| Deep topographic proteomics of a human brain tumour. | Nat Commun | 2023 | 38001067 | PubTator, text mining | PubMed |
| Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years. | Nat Commun | 2023 | 37996417 | PubTator, text mining | PubMed |
| Disruption of the autism gene and chromatin regulator KDM5A alters hippocampal cell identity. | Sci Adv | 2023 | 37992166 | PubTator, text mining | PubMed |
Machine learning-based analysis of cancer cell-derived vesicular proteins revealed significant tumor-specificity and predictive potential of extracellular vesicles for cell invasion and proliferation - A meta-analysis. | Cell Commun Signal | 2023 | 37986165 | PubTator, text mining | PubMed |
| [Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma]. | Zhongguo Fei Ai Za Zhi | 2023 | 37985153 | PubTator, text mining | PubMed |
| Using triple radio-immunotherapy to overcome cancer immunotherapy resistance. | Cancer Biol Med | 2023 | 37975213 | PubTator, text mining | PubMed |
| PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway. | J Transl Med | 2023 | 37974250 | PubTator, text mining | PubMed |
| COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma. | BMC Gastroenterol | 2023 | 37974070 | PubTator, text mining | PubMed |
| Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment. | NPJ Precis Oncol | 2023 | 37964075 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia. | Int J Mol Sci | 2023 | 37958660 | PubTator, text mining | PubMed |
| β-Nicotinamide Mononucleotide Alleviates Hydrogen Peroxide-Induced Cell Cycle Arrest and Death in Ovarian Granulosa Cells. | Int J Mol Sci | 2023 | 37958650 | PubTator, text mining | PubMed |
| Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis. | Int J Mol Sci | 2023 | 37958591 | PubTator, text mining | PubMed |
| PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy. | BMC Cancer | 2023 | 37957639 | PubTator, text mining | PubMed |
| Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma. | Int J Gen Med | 2023 | 37942473 | PubTator, text mining | PubMed |
| Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition. | Cell Biosci | 2023 | 37941042 | PubTator, text mining | PubMed |
| Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. | Cell Death Dis | 2023 | 37938546 | PubTator, text mining | PubMed |
| A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence. | Immun Ageing | 2023 | 37932771 | PubTator, text mining | PubMed |
| Mesenchymal stem cells under epigenetic control - the role of epigenetic machinery in fate decision and functional properties. | Cell Death Dis | 2023 | 37932257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=14